CStone Pharmaceuticals WKN: A2PEFW ISIN: KYG2588M1006 Forum: Aktien Thema: Hauptdiskussion

https://simplywall-st.cdn.ampproject.org/v/s/simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/this-insider-has-just-sold-shares-in-cstone-pharmaceuticals-1/amp?amp_gsa=1&_js_v=a9&usqp=mq331AQIUAKwASCAAgM%3D#amp_tf=Von%20%251%24s&aoh=17580890492538&referrer=https%3A%2F%2Fwww.google.com&share=https%3A%2F%2Fsimplywall.st%2Fstocks%2Fhk%2Fpharmaceuticals-biotech%2Fhkg-2616%2Fcstone-pharmaceuticals-shares%2Fnews%2Fthis-insider-has-just-sold-shares-in-cstone-pharmaceuticals-1

Insiderverkäufe übersteigen die Insiderkäufe. Kein gutes Zeichen

Gewinnmitnahmen nach 130 Prozent Anstieg in 3 Monaten.

Kann mir jemand erklären warum die Aktie so dermaßen abstürzt?

https://www.cstonepharma.com/en/html/news/3833.html

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-schedules-board-meeting-for-interim-results-review

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-advances-phase-iii-study-for-liver-cancer-treatment

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-phase-iii-study-on-cs1001-for-nsclc-a-market-game-changer

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-completes-hk467-28-million-share-placing-to-boost-rd

https://www.ainvest.com/news/cstone-pharma-sell-1-100-million-shares-placement-2507/

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-unveils-promising-bispecific-antibody-targets-for-autoimmune-diseases

https://firstwordpharma.com/story/5963396 https://www.google.com/amp/s/simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/exploring-three-high-growth-tech-stocks-in-asia-7/amp

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-unveils-promising-cancer-therapies-at-aacr-2025

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-advances-clinical-trial-for-innovative-cancer-therapy https://fox4kc.com/business/press-releases/cision/20250305CN34134/cstone-submits-clinical-trial-application-in-australia-for-cs5001-ror1-adc-in-combination-with-first-line-standard-of-care-for-dlbcl/ https://www.koreabiomed.com/news/articleView.html?idxno=26847 https://www.clinicaltrialsarena.com/news/cstone-trial-cs2009/

https://www.tipranks.com/news/company-announcements/cstone-pharmaceuticals-strengthens-board-with-new-appointment

https://ch.marketscreener.com/kurs/aktie/CSTONE-PHARMACEUTICALS-57946082/news/CStone-Pharmaceuticals-gibt-die-Einreichung-eines-Antrags-auf-klinische-Prufung-in-Australien-fur-48642816/?utm_medium=RSS&utm_source=googlenews&utm_content=20241223